Location: Home
  • search
  • go
  • Relate News
  • 9/9/2020SCMP: Chinese Biotech Remains Heated with Surging M&A and IPO Deal...
  • 9/9/2020Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in ...
  • 9/9/2020CDE Issues the Technical Guidelines for Clinical Research of AMD Drugs
  • 9/9/2020CDE Issues the Guidelines on Clinical Pharmacology of Neutralizing Ant...
  • 9/8/2020China Considers to Regulate Online Healthcare Mutual Aid Platforms
  • 9/8/2020CStone's Priority Review NDA for Pralsetinib Accepted in China
  • 9/8/2020CANbridge Enters 2nd Rare Disease Gene Therapy Deal with UMass Med Sch...
  • 9/7/2020Ascentage's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Status by USF...
  • 9/7/2020CPA Releases the List of Excessively-Supplied Drug Products (6th Batch...
  • 9/7/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 9/7/2020Listed Chinese MedPharm Cos Saw Flat Revenue Growth But Higher Net Pro...
  • 9/7/2020Fosun and Sinopharm Enter Deal to Supply BioNTech Coronavirus Vaccine ...
  • 9/6/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 9/4/2020Recent Executive Moves
  • 9/4/2020NHC Announces Its Legislation Plan of Departmental Regulations in 2020
  • 9/4/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...
  • 9/4/2020AbbVie Teams Up with I-Mab in Cancer
  • 9/4/2020Uni-Bio Receives IND Approval for Uni-PTH Liquid Injection in China
  • 9/4/2020CStone Gets Ready to Launch Lung Cancer Drug Sugemalimab in China Befo...
  • 9/3/2020Innovent Granted Marketing Approval for SULINNO (Adalimumab Inj) in Ch...
  • 9/3/2020Alphamab's KN046 Granted Orphan Drug Designation for TET by USFDA
  • 9/3/2020Asymchem Invests in Flow Chemistry Startup Snapdragon
  • 9/3/2020China Tightens Technology Export Control Rules
  • 9/3/2020Chi-Med Initiates PII Trial of HMPL-453 for IHCC in China
  • 9/3/2020Lancet: Chinese Population to Half by 2100 with Sharp Labor Force Decl...
  • 9/3/2020Carlyle Buys Minority Stake in Shenzhen Salubris Pharma
  • 9/2/2020NHC Publishes the List of 2nd Rare Disease Treatment and Insurance Exp...
  • 9/2/2020NMPA Issues the Dispute Resolution Procedures for Drug Evaluation Deci...
  • 9/2/2020CDE Solicits Comments on the Draft Guidelines for Clinical Pharmacolog...
  • 9/2/2020As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Land...
  • Page:237/790 Total number of articles:23678: [First][<<] [235] [236] [237] [238] [239] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group